Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial
Authors:
- 24 January 2022
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 22 (5) , 718-730
Abstract
No abstract availableKeywords
Funding Information
- Meso Scale Diagnostics
- GlaxoSmithKline
- Astellas Pharma Canada
- Biomedical Advanced Research and Development Authority
- Sanofi Pasteur
- F. Hoffmann-La Roche Ltd
- bioMérieux
- F. Hoffmann-La Roche
This publication has 24 references indexed in Scilit:
- Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trialsThe Lancet, 2015
- Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized PatientsClinical Infectious Diseases, 2014
- Detection of Nonhemagglutinating Influenza A(H3) Viruses by Enzyme-Linked Immunosorbent Assay in Quantitative Influenza Virus CultureJournal of Clinical Microbiology, 2014
- Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant dataThe Lancet Respiratory Medicine, 2014
- A Clinical Trial of Intravenous Peramivir Compared with Oral Oseltamivir for the Treatment of Seasonal Influenza in Hospitalized AdultsAntiviral Therapy, 2013
- Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09Clinical Infectious Diseases, 2012
- Diagnosis, management and outcomes of adults hospitalized with influenzaAntiviral Therapy, 2012
- End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life‐Threatening DiseaseThe Journal of Infectious Diseases, 2010
- Clinical Management of Pandemic 2009 Influenza A(H1N1) InfectionChest, 2010
- Nasal Cytokine and Chemokine Responses in Experimental Influenza A Virus Infection: Results of a Placebo‐Controlled Trial of Intravenous Zanamivir TreatmentThe Journal of Infectious Diseases, 1999